Silicon Laboratories’ (SLAB) “Hold” Rating Reiterated at Benchmark

Benchmark reiterated their hold rating on shares of Silicon Laboratories (NASDAQ:SLAB) in a research report sent to investors on Tuesday,Benzinga reports.

A number of other research firms also recently commented on SLAB. JPMorgan Chase & Co. dropped their price objective on shares of Silicon Laboratories from $150.00 to $135.00 and set an “overweight” rating for the company in a research note on Tuesday. StockNews.com raised shares of Silicon Laboratories to a “sell” rating in a research report on Wednesday, October 30th. Barclays dropped their target price on shares of Silicon Laboratories from $120.00 to $75.00 and set an “equal weight” rating for the company in a research report on Tuesday. KeyCorp dropped their target price on shares of Silicon Laboratories from $150.00 to $115.00 and set an “overweight” rating for the company in a research report on Tuesday. Finally, Needham & Company LLC reissued a “buy” rating and set a $150.00 target price on shares of Silicon Laboratories in a research report on Thursday, July 25th. One analyst has rated the stock with a sell rating, five have given a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $121.50.

Silicon Laboratories Price Performance

NASDAQ SLAB opened at $113.65 on Tuesday. Silicon Laboratories has a 12 month low of $92.55 and a 12 month high of $154.91. The company has a 50-day moving average of $112.22 and a 200-day moving average of $115.47. The company has a market cap of $3.67 billion, a P/E ratio of -15.36 and a beta of 1.20.

Silicon Laboratories (NASDAQ:SLAB) last posted its quarterly earnings data on Monday, November 4th. The semiconductor company reported ($0.13) EPS for the quarter, beating analysts’ consensus estimates of ($0.20) by $0.07. Silicon Laboratories had a negative net margin of 46.93% and a negative return on equity of 12.40%. The company had revenue of $166.00 million during the quarter, compared to the consensus estimate of $165.50 million. During the same quarter in the prior year, the company posted $0.48 EPS. The company’s quarterly revenue was down 18.5% compared to the same quarter last year. As a group, equities research analysts anticipate that Silicon Laboratories will post -3.41 EPS for the current year.

Insider Buying and Selling at Silicon Laboratories

In other Silicon Laboratories news, SVP Brandon Tolany sold 845 shares of the stock in a transaction that occurred on Tuesday, September 3rd. The shares were sold at an average price of $115.00, for a total value of $97,175.00. Following the completion of the sale, the senior vice president now owns 43,615 shares of the company’s stock, valued at $5,015,725. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 1.72% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Silicon Laboratories

Several institutional investors and hedge funds have recently made changes to their positions in SLAB. BNP Paribas Financial Markets boosted its stake in shares of Silicon Laboratories by 5.9% during the 1st quarter. BNP Paribas Financial Markets now owns 44,997 shares of the semiconductor company’s stock valued at $6,467,000 after buying an additional 2,526 shares during the last quarter. Fidelis Capital Partners LLC purchased a new position in shares of Silicon Laboratories during the 1st quarter valued at approximately $55,000. Texas Permanent School Fund Corp boosted its stake in shares of Silicon Laboratories by 2.8% during the 1st quarter. Texas Permanent School Fund Corp now owns 27,916 shares of the semiconductor company’s stock valued at $4,012,000 after buying an additional 768 shares during the last quarter. Envestnet Portfolio Solutions Inc. boosted its stake in shares of Silicon Laboratories by 13.5% during the 1st quarter. Envestnet Portfolio Solutions Inc. now owns 5,977 shares of the semiconductor company’s stock valued at $859,000 after buying an additional 709 shares during the last quarter. Finally, SG Americas Securities LLC boosted its stake in shares of Silicon Laboratories by 88.9% during the 1st quarter. SG Americas Securities LLC now owns 1,840 shares of the semiconductor company’s stock valued at $264,000 after buying an additional 866 shares during the last quarter.

Silicon Laboratories Company Profile

Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.